Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03971773
Other study ID # 2018-A00472-53
Secondary ID 2018-A00472-53
Status Recruiting
Phase N/A
First received
Last updated
Start date April 19, 2018
Est. completion date April 18, 2022

Study information

Verified date May 2019
Source Assistance Publique Hopitaux De Marseille
Contact Florence Duffaud, MD/PhD
Email florence.duffaud@ap-hm.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The general aim of the research that we propose to implement is to study the potential benefits of hypnosis in the psycho-social care of patients with cancer. The main goal of this study is to measure the effects of hypnosis sessions on quality of life, anxiety and patient adjustment strategies. The effects of these interventions will be the subject of quantitative measurement via standardized scales in pre- and post-intervention situations of the potential effects of hypno-therapeutic intervention in cancer patients and


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date April 18, 2022
Est. primary completion date April 18, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patient with any kind of cancer and followed by a psychologist

Exclusion Criteria:

- Patient with neurological trouble

- Patient with psychiatric decompassation

Study Design


Related Conditions & MeSH terms


Intervention

Other:
hypnosis
patient with cancer will undergo sessions of hypnosis

Locations

Country Name City State
France Assistance publique hopitaux de Marseille Marseille

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique Hopitaux De Marseille

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary quality of life scale QLQC30 assessment 36 months
Secondary anxiety scales Edmonton Symptom Assessment System 36 months